Skip to main content

Table 1 Basic characteristics of study participants at baseline

From: Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention

Variables

All Patients (n = 2262)

Follow-up Patients (n = 1639)

With MACEs (n = 161)

Cardiovascular risk factors

 Age

60.04 ± 10.73

60.57 ± 10.81

59.45 ± 10.65

 Gender, (n)men%

1675 (74.05%)

1201 (73.28%)

113 (70.19%)*

 BMI

24.37 ± 4.08

24.34 ± 4.30

23.76 ± 3.28

 Hypertension, n (%)

1301 (57.51%)

945 (57.66%)

101 (62.73%)#

 hyperlipidemia, n (%)

149 (6.59%)

99 (6.04%)

10 (6.21%)

 Diabetes, n (%)

425 (18.79%)

317 (19.34%)

47 (29.19%)#

 Current/ex-smoker, n (%)

1149 (50.79%)

818 (49.91%)

85 (52.79%)*

 Alcohol consumption (units per week), n (%)

695 (30.73%)

503 (30.69%)

45 (27.95%)*

 Previous myocardial infarction, n (%)

235 (10.39%)

152 (9.27%)

18 (11.18%)*

 Heart failure, n (%)

35 (1.55%)

25 (1.52%)

5 (3.11%)*

 History of cerebrovascular disease, n (%)

157 (6.94%)

117 (7.13%)

14 (8.69%)*

Biomarkers

 TC (mmol/L)

4.33 ± 1.74

4.33 ± 1.66

4.31 ± 1.56

 HDL-C (mmol/L)

1.07 ± 0.55

1.06 ± 0.47

1.09 ± 0.78

 LDL-C (mmol/L)

2.50 ± 0.95

2.49 ± 0.93

2.52 ± 0.92*

 TG (mmol/L)

1.89 ± 1.63

1.89 ± 1.56

1.84 ± 1.32

 ApoA1(g/L)

1.18 ± 0.48

1.20 ± 0.55

1.15 ± 0.32

 ApoB(g/L)

0.89 ± 0.49

0.90 ± 0.53

1.02 ± 0.79*

Blood pressure (mm Hg)

 Systolic

140 ± 14.17

140 ± 15.23

141 ± 15.78

 Diastolic

80 ± 13.19

80 ± 13.25

84 ± 12.86*

Coronary angiography

 1-vessel disease, n (%)

683 (30.19%)

497 (30.32)

34 (21.12%)#

 2-vessel disease, n (%)

712 (31.47%)

515 (31.42)

42 (26.08%)#

 3-vessel disease, n (%)

867 (38.32%)

626 (38.19)

85 (52.80%)#

  1. All values are presented as mean ± SD, or number (%). BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, TG triglycerides, ApoA1 apolipoproteinA1, ApoB apolipoproteinB. *p < 0.05(With MACEs Vs. Follow-up Patients); #p < 0.01(With MACEs Vs. Follow-up Patients)